

TreeFrog Therapeutics receives additional €3M non-dilutive funding to mass-produce clinical-grade cell therapies by 2021

Robocath raises €5 million and announces the appointment of Lucien Goffart as new CEO

Alizé Pharma 3 raises €67 million ($75 million) in Series A from a strong international syndicate

Traxens closes €20M Series C financing round with key strategic partners

Imcyse secures total of €35M in Series B financing round and additional grants

Seventure Partners renews support to Domain Therapeutics and invests €3.5M
A.P. Moller – Maersk will join Traxens

TreeFrog Therapeutics raises over €7M ($7.8M) in Series A financing round 6 months after incorporation
